Shandong Sinobioway Biomedicine Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 82.564 million compared to CNY 101.885 million a year ago. Operating income was CNY 20.878 million compared to operating loss of CNY 44.780 million a year ago. Net income was CNY 24.391 million compared to net loss of CNY 62.820 million a year ago. Basic earnings per share from continuing operations was CNY 0.037 compared to basic loss per share from continuing operations of CNY 0.0952 a year ago.